| 000 | 01392 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516082616.0 | ||
| 264 | 0 | _c20120907 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/jm201649s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Jonathan A | |
| 245 | 0 | 0 |
_aModern phenotypic drug discovery is a viable, neoclassic pharma strategy. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMay 2012 |
||
| 300 |
_a4527-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aData Mining |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xtrends |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 |
_aDrug Industry _xmethods |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 |
_aHigh-Throughput Screening Assays _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aResearch _xtrends |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aUhlik, Mark T | |
| 700 | 1 | _aMoxham, Christopher M | |
| 700 | 1 | _aTomandl, Dirk | |
| 700 | 1 | _aSall, Daniel J | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 55 _gno. 10 _gp. 4527-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm201649s _zAvailable from publisher's website |
| 999 |
_c21614844 _d21614844 |
||